Trading volume was 19.9 times its 30-day average, The stock rose 10.2 percent so far this year.
Shares of the drugmaker rose as much as 8.7 percent, the most in over a year, to trade near a two-month high at Rs 2,655.
Pharmaceuticals
Cipla Swings On Acquisition Plans – Gold Silver Reports
The drugmaker plans to acquire 33 percent stake in Avenue Therapeutics for $35 million at $6 per share, according to its stock exchange notification.
Shares of the pharmaceutical company fluctuated between gains and losses to trade at Rs 528.40.
Dr. Reddy’s Labs Drops On Repeat Observations For Duvvada Plant
Dr. Reddy’s Labs Drops On Repeat Observations For Duvvada Plant – Shares of the Hyderabad-based drug maker fell as much as 2.61 percent to Rs 2,389 after it received eight observations, five of them a repeat of 2017 and warning letter of 2015, from the U.S. drug regulator at its Duvvada facility—crucial for future growth prospects in its largest market.